There are 2789 resources available
1811P - Molecular characterization of epidermal growth factor receptor-mutated (EGFR-m) non-small cell lung cancer (NSCLC) undergoing histological transformation
Presenter: Laura Bonanno
Session: ePoster Display
1812P - Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
Presenter: Franziska Kraus
Session: ePoster Display
1813P - Anlotinib plus osimertinib overcomes acquired resistance to osimertinib via FGFR and EGFR signaling in non-small cell lung cancer (NSCLC)
Presenter: Qiong Zhao
Session: ePoster Display
1689P - Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials
Presenter: James Gulley
Session: ePoster Display
1589P - Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options
Presenter: Melanie Zemel
Session: ePoster Display
1590P - Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies
Presenter: Kristina Zakurdaeva
Session: ePoster Display
1744P - Serum TSH level: A simple efficient tool to assess risk of thyroid malignancy in euthyroid patients with indeterminate cytology
Presenter: Ashwin Vinod
Session: ePoster Display
1745P - Prediction of BSRTC class of repeated FNA based on molecular testing result upon the first FNA
Presenter: Yuntao Song
Session: ePoster Display
1814P - Molecular profile and clinical data of patients with lung cancer harboring germline TP53 R337H mutation
Presenter: Carlos Diego Lopes
Session: ePoster Display